| HGNC Family | Non-coding RNAs |
| Name | microRNA 96 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR‑96 is a multifunctional microRNA whose dysregulation has been implicated in a wide range of human malignancies. In several breast and prostate cancers, increased miR‑96 expression promotes cellular proliferation, invasion, and survival through direct repression of key tumor suppressors such as FOXO1, FOXO3, and RECK. In some contexts, miR‑96 also modulates DNA repair and chemosensitivity by targeting factors including RAD51 and REV1, whereas in non‑small cell lung cancer, exosomal miR‑96 enhances viability, migration, and drug resistance by downregulating targets like LMO7. Conversely, in pancreatic and colorectal cancers, miR‑96 can act in a tumor‑suppressive role by directly targeting KRAS or, in a related mechanism, its suppression by oncogenic factors (e.g., EVI1) drives KRAS upregulation. Additional studies in hepatocellular and esophageal cancers have linked miR‑96 overexpression to reduced apoptosis and enhanced oncogenic signaling, while in bladder cancer its upregulation is associated with increased IRS1 and MAP4K1 expression that supports tumor growth."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in tumor biology, miR‑96 is critical for normal development and cellular homeostasis. Point mutations within its seed region have been directly linked to autosomal dominant, progressive sensorineural hearing loss due to impaired miR‑96 biogenesis and target regulation. In the hematologic compartment, miR‑96 directly suppresses γ‑globin expression, contributing to the fetal-to‑adult hemoglobin switch, while during neuroectoderm specification it modulates developmental programs via targeting transcription factors such as PAX6. miR‑96 has also been shown to influence hepatic cholesterol metabolism by repressing the scavenger receptor SR‑BI and to regulate autophagy in prostate cancer cells in a dose‑dependent manner."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe regulatory networks governing miR‑96 activity further underscore its contextual complexity. Several long non‑coding RNAs—as exemplified by TP53TG1, GMDS‑AS1, and STXBP5‑AS1—act as competing endogenous RNAs to sequester miR‑96, thereby modulating the expression of key targets such as KRAS, CYLD, and PTEN in pancreatic, lung, and cervical cancers. In addition, upstream signals including TGF‑β and autocrine/paracrine growth hormone signaling can regulate miR‑96 levels, thereby influencing processes like epithelial‑mesenchymal transition and bone metastasis. Moreover, as a member of the evolutionarily conserved miR‑183/96/182 cluster, miR‑96 contributes to dynamic alterations in gene expression that underlie tumor progression and metastasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Irene K Guttilla, Bruce A White "}, {"type": "b", "children": [{"type": "t", "text": "Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.031427"}], "href": "https://doi.org/10.1074/jbc.M109.031427"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19574223"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19574223"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Shuangni Yu, Zhaohui Lu, Changzheng Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-4531"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-4531"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20610624"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20610624"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Huanxin Lin, Ting Dai, Huaping Xiong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0015797"}], "href": "https://doi.org/10.1371/journal.pone.0015797"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21203424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21203424"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yemin Wang, Jen-Wei Huang, Philamer Calses, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-12-0103"}], "href": "https://doi.org/10.1158/0008-5472.CAN-12-0103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22761336"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22761336"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yeting Hong, Hongwei Liang, Uzair-Ur-Rehman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep37421"}], "href": "https://doi.org/10.1038/srep37421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27857177"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27857177"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Benedikta S Haflidadóttir, Olivia Larne, Myriam Martin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0072400"}], "href": "https://doi.org/10.1371/journal.pone.0072400"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23951320"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23951320"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Annika Fendler, Monika Jung, Carsten Stephan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0080807"}], "href": "https://doi.org/10.1371/journal.pone.0080807"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24260486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24260486"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Anna Lena Ress, Verena Stiegelbauer, Elke Winter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.22218"}], "href": "https://doi.org/10.1002/mc.22218"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25256312"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25256312"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hao Wu, Jingcheng Zhou, Shanshan Mei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.13056"}], "href": "https://doi.org/10.1111/jcmm.13056"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28026121"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28026121"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Naoto Iwai, Kohichiroh Yasui, Akira Tomie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2018.4369"}], "href": "https://doi.org/10.3892/ijo.2018.4369"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29658604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29658604"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Haifeng Xia, Shaomu Chen, Ke Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2014.10.023"}], "href": "https://doi.org/10.1016/j.biopha.2014.10.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25465153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25465153"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Haizhou Guo, Qianping Li, Weihao Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-014-1966-x"}], "href": "https://doi.org/10.1007/s11010-014-1966-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24469470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24469470"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Junfeng Zhang, Xiangjie Kong, Jia Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2013.2934"}], "href": "https://doi.org/10.3892/or.2013.2934"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24366472"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24366472"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "M Tanaka, H I Suzuki, J Shibahara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.204"}], "href": "https://doi.org/10.1038/onc.2013.204"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23752186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23752186"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Tong-Hong Wang, Chau-Ting Yeh, Jar-Yi Ho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.22286"}], "href": "https://doi.org/10.1002/mc.22286"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25663355"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25663355"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yi Wang, Hongmei Luo, Yangle Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2011.621"}], "href": "https://doi.org/10.3892/mmr.2011.621"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21993544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21993544"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Feng Gao, Wenhui Wang "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2014.2854"}], "href": "https://doi.org/10.3892/mmr.2014.2854"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25369914"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25369914"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Angeles Mencía, Silvia Modamio-Høybjør, Nick Redshaw, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.355"}], "href": "https://doi.org/10.1038/ng.355"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19363479"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19363479"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Giulia Soldà, Michela Robusto, Paola Primignani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddr493"}], "href": "https://doi.org/10.1093/hmg/ddr493"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22038834"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22038834"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Imane Azzouzi, Hansjoerg Moest, Jeannine Winkler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-96 directly inhibits γ-globin expression in human erythropoiesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0022838"}], "href": "https://doi.org/10.1371/journal.pone.0022838"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21829531"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21829531"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Zhong-Wei Du, Li-Xiang Ma, Christian Phillips, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-200 and miR-96 families repress neural induction from human embryonic stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Development (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/dev.092809"}], "href": "https://doi.org/10.1242/dev.092809"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23637338"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23637338"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Li Wang, Xiao-Jian Jia, Hua-Jun Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01580-12"}], "href": "https://doi.org/10.1128/MCB.01580-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23459944"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23459944"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yi Ma, Hao-Zheng Yang, Bai-Jun Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biphasic regulation of autophagy by miR-96 in prostate cancer cells under hypoxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.2396"}], "href": "https://doi.org/10.18632/oncotarget.2396"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25333253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25333253"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yufeng Zhang, Haiyan Yang, Yong Du, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14136"}], "href": "https://doi.org/10.1111/cas.14136"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31325400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31325400"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Ming Zhao, Xiao-Feng Xin, Jian-Ya Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.2776"}], "href": "https://doi.org/10.1002/cam4.2776"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31860169"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31860169"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Shiqing Shao, Chen Wang, Shelian Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109082"}], "href": "https://doi.org/10.1016/j.biopha.2019.109082"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31212131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31212131"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "M K Siu, Y-C Tsai, Y-S Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.414"}], "href": "https://doi.org/10.1038/onc.2014.414"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25531317"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25531317"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Weijie Zhang, Pengxu Qian, Xiao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.653261"}], "href": "https://doi.org/10.1074/jbc.M115.653261"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25873390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25873390"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Pei Li, Cheng Sheng, Lingling Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13058-014-0473-z"}], "href": "https://doi.org/10.1186/s13058-014-0473-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25394902"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25394902"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Xiao Ling Li, Toshifumi Hara, Youngeun Choi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01043-13"}], "href": "https://doi.org/10.1128/MCB.01043-13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24277930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24277930"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Yi Ma, A-Juan Liang, Yu-Ping Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.8715"}], "href": "https://doi.org/10.18632/oncotarget.8715"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27081087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27081087"}]}]}]}
|
| Synonyms | DFNA50, MIRNA96, HSA-MIR-96, MIR-96, MIRN96 |
| NCBI Gene ID | 407053 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR96 has 940 functional associations with biological entities spanning 6 categories (molecular profile, functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 24 datasets.
Click the + buttons to view associations for MIR96 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR96 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with MIR96 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR96 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with MIR96 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR96 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MIR96 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR96 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR96 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR96 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR96 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR96 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR96 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR96 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with MIR96 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MIR96 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by MIR96 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR96 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR96 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MIR96 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR96 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by MIR96 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with MIR96 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR96 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MIR96 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |